Cross design analysis of randomized and observational data – application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults

被引：0
作者：
Tatsiana Vaitsiakhovich
Anna Filonenko
Richard Lynen
Jan Endrikat
Christoph Gerlinger
机构：
[1] RWE Strategy & Outcomes Data Generation,Gynecology, Obstetrics and Reproductive Medicine
[2] Bayer AG,undefined
[3] Market Access Pulmonology and Women’s Healthcare,undefined
[4] Bayer AG,undefined
[5] US Medical Affairs Women’s Healthcare,undefined
[6] Bayer U.S. LLC,undefined
[7] Radiology,undefined
[8] Bayer AG,undefined
[9] University of Saarland Medical School,undefined
[10] Statistics and Data Insights,undefined
[11] Bayer AG,undefined
来源：
BMC Women's Health | / 18卷
关键词：
Cross design syntheses; Continuation rates; Intra-uterine device;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
[1]  
Verde PE(2016)Bayesian evidence synthesis for exploring generalizability of treatment effects: a case study of combining randomized and non-randomized results in diabetes Stat Med 35 1654-1675
[2]  
Ohmann C(2015)Combining randomized and non-randomized evidence in clinical research: a review of methods and applications Res Synth Methods 6 45-62
[3]  
Morbach S(2011)Estimating treatment effect via simple cross design synthesis Stat Med 30 2986-3009
[4]  
Icks A(1996)How effective are contraceptives? The determination and measurement of pregnancy rates Obstet Gynecol 88 13S-23S
[5]  
Verde PE(2015)Young age, Nulliparity, and continuation of long-acting reversible contraceptive methods Obstet Gynecol 126 823-829
[6]  
Ohmann C(2003)Recommendation for confidence interval and sample size calculation for the pearl index Eur J Contracept Reprod Health Care 8 87-92
[7]  
Kaizar EE(2012)A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena Fertil Steril 97 616-622
[8]  
Potter LS(2010)The contraceptive CHOICE project: reducing barriers to long-acting reversible contraception Am J Obstet Gynecol 203 115 e111-115 e117
[9]  
Abraham M(undefined)undefined undefined undefined undefined-undefined
[10]  
Zhao Q(undefined)undefined undefined undefined undefined-undefined
123